indole-3-carbaldehyde has been researched along with Hormone-Dependent Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gastpar, R; Goldbrunner, M; Marko, D; von Angerer, E | 1 |
Chen, HY; Chen, LR; Hsiao, PW; Ke, FC; Lin, EH; Lin, FM; Tsai, MJ | 1 |
2 other study(ies) available for indole-3-carbaldehyde and Hormone-Dependent Neoplasms
Article | Year |
---|---|
Methoxy-substituted 3-formyl-2-phenylindoles inhibit tubulin polymerization.
Topics: Animals; Antineoplastic Agents; Biopolymers; Brain; Breast Neoplasms; Cattle; Colchicine; Drug Screening Assays, Antitumor; Female; Humans; Indoles; Inhibitory Concentration 50; Microscopy, Fluorescence; Neoplasms, Hormone-Dependent; Protein Binding; Structure-Activity Relationship; Tubulin; Tubulin Modulators; Tumor Cells, Cultured | 1998 |
Compounds from Wedelia chinensis synergistically suppress androgen activity and growth in prostate cancer cells.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Apigenin; Cell Line, Tumor; Cell Proliferation; Coumarins; Drug Synergism; Humans; Indoles; Luteolin; Male; Neoplasms, Hormone-Dependent; Plant Extracts; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Wedelia | 2007 |